Investors
News
Contact

About us
Inhalers
- Inhalers
- ICOres
- ICOcap
- ICOpre
- ICOone
- ICOone Nasal
- Patents
Development capabilities
Partner with us
- Partner with us
- Access our inhalers
Insights
Investors
Search
Menu Menu

Erbjudandet i Iconovo övertecknat inför börsnotering på First North (only in Swedish)

March 26, 2018/in News /by Eva Norell

Erbjudandet i Iconovo övertecknat inför börsnotering på First North. Pressrelease_Iconovo 2018-03-26

Share this entry

Share on Twitter
Share on LinkedIn
Share by Mail

https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png 0 0 Eva Norell https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png Eva Norell2018-03-26 17:36:562018-03-26 17:36:56Erbjudandet i Iconovo övertecknat inför börsnotering på First North (only in Swedish)

Possessing a unique combination

of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.

ICONOVO AB

VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B

POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden

CONTACT

Phone: +46 46 275 67 77

VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se

CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se

SITEMAP

Home
Development capabilities
Investors

Press releases

Interview with Dr. Orest Lastow, CEO Iconovo (only in Swedish) Iconovo to Nasdaq first North

Scroll to top